Progress in Antimalarial Drug Development
After a resurgence in malaria burden over the last few decades, malaria specialists are once again talking about eradicating or eliminating the disease. Chris Hentschel, president and chief executive officer of the Medicines for Malaria Venture, explains why.
For more on this topic, see the eBriefing Progress against Malaria: Developments on the Horizon.